Common Contracts
6 similar Underwriting Agreement contracts by BioSig Technologies, Inc., Amesite Inc., Infrastructure & Energy Alternatives, Inc., Ryman Hospitality Properties, Inc.
4,341,667 Shares BIOSIG TECHNOLOGIES, INC. Common Stock AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • June 29th, 2022 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
BioSig Technologies, Inc., a Delaware corporation (the “Company”), subject to the terms and conditions herein, proposes to sell to the underwriters (the “Underwriters”) named in Schedule I attached to this agreement (this “Agreement”), on a best efforts basis, 4,341,667 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). This Amended and Restated Underwriting Agreement amends, restates and supersedes in its entirety the prior underwriting agreement dated as of June 24, 2022, by and between the Company and the Representative.
4,666,667 Shares BIOSIG TECHNOLOGIES, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 29th, 2022 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
BioSig Technologies, Inc., a Delaware corporation (the “Company”), subject to the terms and conditions herein, proposes to sell to the underwriters (the “Underwriters”) named in Schedule I attached to this agreement (this “Agreement”), on a best efforts basis, 4,666,667 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”).
AMESITE INC. Common Stock AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • February 16th, 2022 • Amesite Inc. • Services-prepackaged software • New York
Amesite Inc. (f/k/a Amesite Operating Company), a Delaware corporation (the “Company”), subject to the terms and conditions herein, proposes to sell to the underwriters (the “Underwriters”) named in Schedule I attached to this agreement, on a best efforts basis, up to 3,750,000 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). This Amended and Restated Underwriting Agreement (this “Agreement”) amends, restates and supersedes in its entirety the prior Underwriting Agreement dated February 11, 2022 (the “Original Signing Date”) by and between the Company and the Underwriters.
8,161,502 Shares of Common Stock 7,747,589 Pre-Funded Warrants INFRASTRUCTURE & ENERGY ALTERNATIVES, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • July 30th, 2021 • Infrastructure & Energy Alternatives, Inc. • Blank checks • New York
Guggenheim Securities, LLC As Representative of the several Underwriters named in Schedule I attached hereto c/o Guggenheim Securities, LLC 330 Madison Avenue New York, New York 10017
2,500,000 Shares BIOSIG TECHNOLOGIES, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • July 6th, 2021 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
BioSig Technologies, Inc., a Delaware corporation (the “Company”), subject to the terms and conditions herein, proposes to sell to the underwriters (the “Underwriters”) named in Schedule I attached to this agreement (this “Agreement”) 2,500,000 shares (the “Firm Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). In addition, the Company proposes to grant to the Underwriters an option to purchase up to 375,000 additional shares of Common Stock on the terms set forth in Section 2 (the “Option Shares”). The Firm Shares and the Option Shares, if and to the extent such option is exercised, are hereinafter collectively called the “Shares.”
RYMAN HOSPITALITY PROPERTIES, INC. 3,000,000 Shares of Common Stock ($0.01 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • December 12th, 2019 • Ryman Hospitality Properties, Inc. • Real estate investment trusts • New York
Ryman Hospitality Properties, Inc., a Delaware corporation (the "Company"), proposes to sell to the several underwriters named on Schedule 1 hereto (the "Underwriters") for whom you are acting as representatives (the "Representatives"), 3,000,000 shares (the "Firm Shares") of the Company's Common Stock, $0.01 par value per share (the "Common Stock"). In addition, the Company proposes to grant to the Underwriters an option to purchase up to an aggregate of 450,000 additional shares of the Common Stock on the terms set forth in Section 2 (the "Option Shares"). The Firm Shares and the Option Shares, if purchased, are hereinafter collectively called the "Shares." This is to confirm the agreement concerning the purchase of the Shares from the Company by the Underwriters.
